Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis
ICD-10 N07.5 is a billable code used to indicate a diagnosis of hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis.
N07.5 refers to a specific type of hereditary nephropathy characterized by diffuse mesangiocapillary glomerulonephritis. This condition is often associated with genetic mutations that affect the kidney's filtering units, leading to proteinuria and potential progression to chronic kidney disease. Patients may present with isolated proteinuria, which can be a key indicator of underlying glomerular disorders. The hereditary nature of this nephropathy suggests a familial pattern, often necessitating genetic testing to identify specific mutations. The diffuse mesangiocapillary glomerulonephritis component indicates a particular histological pattern observed in kidney biopsies, characterized by mesangial cell proliferation and capillary wall thickening. This condition may not fit neatly into other classifications of kidney disease, making accurate coding essential for appropriate management and treatment planning.
Detailed clinical history, genetic testing results, and biopsy findings.
Patients presenting with unexplained proteinuria, family history of kidney disease, and abnormal kidney function tests.
Ensure that genetic testing results are included in the documentation to support the hereditary diagnosis.
Family history, genetic testing results, and interpretation of genetic findings.
Patients referred for genetic counseling due to family history of nephropathy.
Document the rationale for genetic testing and any findings that may influence treatment.
Used when genetic testing is performed to confirm a diagnosis of hereditary nephropathy.
Documentation of the clinical rationale for testing and results.
Nephrology specialists should ensure that genetic testing is clearly linked to the diagnosis.
Genetic testing is crucial for confirming the hereditary nature of nephropathy, identifying specific mutations, and guiding treatment options. It also helps in assessing the risk for family members.
